Itonic Holdings Ltd. (NASDAQ:ITOC) Sees Significant Growth in Short Interest

Itonic Holdings Ltd. (NASDAQ:ITOC) was the target of a significant growth in short interest in April. As of April 30th, there was short interest totaling 344,406 shares, a growth of 115.6% from the April 15th total of 159,717 shares. Currently, 2.0% of the shares of the stock are short sold. Based on an average daily volume of 4,386,228 shares, the short-interest ratio is currently 0.1 days.

Itonic Stock Down 2.3%

Itonic stock opened at $0.30 on Friday. The business’s fifty day simple moving average is $0.33. Itonic has a 52-week low of $0.25 and a 52-week high of $32.00.

Itonic (NASDAQ:ITOC) last posted its quarterly earnings results on Monday, March 30th. The company reported ($0.09) earnings per share for the quarter. The firm had revenue of $0.23 million for the quarter.

Analyst Ratings Changes

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Itonic in a research note on Friday, May 8th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, Itonic currently has a consensus rating of “Sell”.

About Itonic

iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients.